📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. (2018)

First Author: Mueller S

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nature25459

PubMed Identifier: 29364867

Publication URI: http://europepmc.org/abstract/MED/29364867

Type: Journal Article/Review

Volume: 554

Parent Publication: Nature

Issue: 7690

ISSN: 0028-0836